Key facts
- This page summarizes David D. Halbert's Form 4 filing for Caris Life Sciences, Inc. (CAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 10 Mar 2026, 17:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Award
No transaction description listed
| Id | Content |
|---|---|
| F1 | Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |
| F2 | The Common Stock reported herein includes (i) 76,261,532 shares of Common Stock held of record by Caris Halbert, L.P., (ii) 8,528,805 shares of Common Stock held of record by ADAPT I Ltd., (iii) 8,414,427 shares of Common Stock held of record by Carisome I, L.P., (iv) 645,149 shares of Common Stock held of record by Caris Investment II Ltd, (v) 2,175,089 shares of Common Stock held of record by Caris Investment III Ltd, and (vi) 25,000,000 shares held of record by Halbert Family Capital, LLC. Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. Caris Halbert, L.P. is the managing member of Halbert Family Capital, LLC. |
| F3 | David Dean Halbert is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Founder, Chairman, and Chief Executive Officer